Journal article
The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised
- Abstract:
-
We would like to congratulate Bafadhel et al on their excellent paper examining the response to Budesonide and blood eosinophils counts (on line version 10th Jan) in COPD. In clearly demonstrating the continuous nature of the relationship between blood eosinophil count and the risk of exacerbations as well the benefit of inhaled corticosteroids in COPD, they have helped clarify a point that we alluded to in our original paper1 that the nature of the response is “graded” dependent on the eosin...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 278.8KB)
-
- Publisher copy:
- 10.1016/s2213-2600(18)30137-1
Authors
Funding
GlaxoSmithKline
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lancet Respiratory Medicine Journal website
- Volume:
- 6
- Issue:
- 5
- Pages:
- e18
- Publication date:
- 2018-04-05
- Acceptance date:
- 2018-03-15
- DOI:
- EISSN:
-
2213-2619
- ISSN:
-
2213-2600
- Pmid:
-
29627194
- Source identifiers:
-
842699
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:842699
- UUID:
-
uuid:07435dbd-8174-4b41-91a7-1d4a8a93a6fc
- Local pid:
- pubs:842699
- Deposit date:
- 2018-07-19
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2018
- Notes:
- © 2018 Elsevier Ltd. All rights reserved. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/S2213-2600(18)30137-1
If you are the owner of this record, you can report an update to it here: Report update to this record